日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Mitigate Liver Fibrosis by Delivering USP10 to Reprogram Macrophage Phenotype.

工程化间充质干细胞衍生的小细胞外囊泡通过递送 USP10 重编程巨噬细胞表型来减轻肝纤维化

Tian Siyuan, Zhou Xia, Zheng Linhua, Liu Jingyi, Zhang Miao, Ma Shuoyi, Zheng Xiaohong, Guo Guanya, Ju Ruobing, Yang Fangfang, Liu Yansheng, Li Bo, Hu Yinan, Xia Erzhuo, Su Rui, Sun Keshuai, Cui Lina, Guo Changcun, Zhou Xinmin, Wang Jingbo, Shang Yulong, Han Ying

Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteria

基于 BAVENO VII 标准,对接受熊去氧胆酸治疗的原发性胆汁性胆管炎相关失代偿性肝硬化患者的再代偿进行定义和验证

Ding, Dawei; Cui, Lina; Jia, Gui; Wang, Boling; Zheng, Linhua; Deng, Juan; Sun, Ruiqing; Wang, Xiufang; Shang, Yulong; Guo, Guanya; Han, Ying

Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial

现成的人脐带间充质干细胞产品治疗急性加慢性肝衰竭:一项多中心 I/II 期临床试验

Cui, Lina; Zou, Huaibin; You, Shaoli; Guo, Changcun; Gu, Jundong; Shang, Yulong; Jia, Gui; Zheng, Linhua; Deng, Juan; Wang, Xiufang; Sun, Ruiqing; Ding, Dawei; Wang, Weijie; Zhou, Xia; Guo, Guanya; Liu, Yansheng; Han, Zhongchao; Han, Zhibo; Chen, Yu; Han, Ying

Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment

原发性胆汁性胆管炎伴明显肝脏硬度的低风险患者:预后和治疗

Ding, Dawei; Hu, Yinan; Jia, Gui; Wang, Boling; Zheng, Linhua; Deng, Juan; Sun, Ruiqing; Wang, Xiufang; Guo, Guanya; Cui, Lina; Shang, Yulong; Han, Ying

Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system

识别失代偿期肝硬化患者自体外周血干细胞治疗的最佳候选者:预后评分系统

Tian, Siyuan; Guo, Guanya; Zhou, Xia; Liu, Yansheng; Jia, Gui; Zheng, Linhua; Cui, Lina; Wang, Kemei; Zhang, Miao; Sun, Keshuai; Ma, Shuoyi; Yang, Chunmei; Zhou, Xinmin; Guo, Changcun; Shang, Yulong; Han, Ying

Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria

肝脏硬度在原发性胆汁性胆管炎患者中的预后意义:Baveno VII 标准的验证

Ding, Dawei; Guo, Guanya; Cui, Lina; Jia, Gui; Wang, Xiufang; Zhang, Miao; Tian, Siyuan; Zheng, Linhua; Liu, Yansheng; Hu, Yinan; Xuan, Guoyun; Yang, Jiaqi; Yang, Chunmei; Sun, Ruiqing; Deng, Juan; Guo, Changcun; Chen, Yu; Shang, Yulong; Han, Ying

Extended Kalman filter-based robust roll angle estimation method for spinning vehicles

基于扩展卡尔曼滤波器的旋转车辆鲁棒横滚角估计方法

Feng, Lu; Wu, Peng; Zheng, Linhua; Tong, Haibo; Shi, Haonan; Wang, Yong

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion

预测和评估接受熊去氧胆酸治疗的原发性胆汁性胆管炎高危患者:早期标准

Yang, Chunmei; Guo, Guanya; Li, Bo; Zheng, Linhua; Sun, Ruiqing; Wang, Xiufang; Deng, Juan; Jia, Gui; Zhou, Xia; Cui, Lina; Guo, Changcun; Zhou, Xinmin; Leung, Patrick S C; Gershwin, M Eric; Shang, Yulong; Han, Ying

A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming

新型小分子糖酵解抑制剂WZ35通过代谢重编程发挥抗癌作用

Lihua Wang #, Zheng Zhu #, Qi Liang #, Yecheng Tao #, Gaowei Jin, Yaoyao Zhong, Jichen Dai, Ruixia Dai, Zhixiang Wang, Junbo Chen, Lingjie Zhou, Shouyu Ke, Bin Zheng, Linhua Lan, Xiaokun Lin, Tongke Chen

Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid

非诺贝特辅助治疗对熊去氧胆酸治疗反应不佳的肝硬化原发性胆汁性胆管炎患者的疗效和安全性

Ding, Dawei; Guo, Guanya; Liu, Yansheng; Zheng, Linhua; Jia, Gui; Deng, Juan; Sun, Ruiqing; Wang, Xiufang; Guo, Changcun; Shang, Yulong; Han, Ying